About Menu Who We Are Mission & Vision Company Profile Chairman Letter Board of Directors Executives Founders Certificates Samer M. NajjarChairman of Board of DirectorsEducationB.Sc. Pharmacy, Professor in Drug DiscoveryBackground & AchievementsMore than twenty years of experience in pharmaceutical research. 7 Years of them as R&D Manager at Joswe Pharmaceutical Company (fast growing company) and being responsible for the development of their pipeline. Good knowledge and experience of analytical methods development, validation, pre-formulation, stability testing, and scaling up of products. Good knowledge and experience of regulatory filing including CTD dossier preparation and response to regulatory inquiries. Good knowledge of Intellectual Property Rights issues related to formulation and registration processes. Good knowledge of pharmacokinetics related to drug development and conduction of bioequivalence studies, with solid experience in monitoring and auditing of bioequivalence studies and CRO's. Good knowledge and experience in cGMP and on-site inspection. Member of Jordanian Food and Drug Administration committees for quality control and site inspection/approval. Author and co-author in several publications in reputable pharmaceutical journals. Professor Mohammad KhalilFounder and Consultant/Board MemberEducationB.Sc. Pharmacy, Professor in Drug DiscoveryBackground & AchievementsU.S.-licensed pharmacist (NAPLEX) with PhD in Medicinal & Biological Chemistry (University of Toledo, GPA 4.0).Former Director General of ACDIMA (2015–2024) and current board member of the Jordan Food & Drug Administration, with multiple past chair/board roles across MENA pharma companies.Professor of Pharmaceutical Sciences at the University of Jordan (2005–2020), contributing to academic development and graduate supervision. Key contributor to regional regulatory policy, including Arab Harmonized Bioequivalence Guidelines and committees on biosimilars, quality, and re-registration.Scientific expertise spans drug design (enzyme inhibition, QSAR/pharmacophore), bioequivalence, biosimilar evaluation, analytical validation, immunomodulation, and natural products pharmacology. Widely published author and presenter at international forums (WHO, SFDA, AUPAM, EUFEPS/AAPS).Supervisor of diverse Master’s and PhD research projects and active peer reviewer.Integrates scientific rigor, multinational governance, and regulatory insight to support strategic growth and innovation in pharmaceutical enterprises. Professor Naji M. NajibProfessor of PharmaceuticsEducationB.Sc. degree in pharmacy from Leicester England in 1976 and the Ph.D. in Pharmaceutics from Nottingham University 1979 Background & AchievementsDean of the pharmacy school (1991-1994) & Dean of post graduate studies (1994-1999) at the Jordanian University of Science & TechnologyProfessor Najib authored more than 100 research articles published in highly reputable journals in the field of drug delivery, pro-drugs, physical pharmaceutics and bioavailability-bioequivalence studies. Professor Najib is the Chairman, CEO and founder of International Pharmaceutical Research Center IPRC
